Catalysts

WHITE PAPERS AND CASE STUDIES

• Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline

  Meeting tight launch timelines requires more than speed. Smart kit design, controlled production workflows, and scalable processes come together to deliver complex packaging programs quickly.

• Online Total Nitrogen Analysis Of Reverse Osmosis Reject Water Reduces Permit Compliance Expense By $350,000 Annually At Beverage Bottling Plant

  Learn how a beverage plant cut its annual Reverse Osmosis reject water hauling volume by 50%. Real-time Total Nitrogen monitoring reduced compliance costs by $350,000 and eliminated discharge penalty risk.

• Boosting Quality And Reducing Complexity With A Single-Provider PV Solution

  Discover how a German biopharmaceutical company successfully managed growing global pharmacovigilance complexity across more than 2,300 marketing authorizations and a broad partner network.

• Robust, Scalable Strategy For Monodisperse Nanosuspensions Of Poorly Soluble Drugs

  By tailoring the formulation strategy, selecting the appropriate excipients, and fine-tuning process conditions, see how our team was able to improve bioavailability and in vivo exposure.

• Executing Concurrent Decentralized RCTs And RWE At Scale

  See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

• High Drug Tolerance ADA Testing For Long‑Acting mAbs

  See how advanced ADA assay design overcomes extreme drug interference, enabling reliable immunogenicity assessment for long‑acting, high‑dose monoclonal antibodies in early clinical development.

• Secondary Packaging: Labeling, Cartoning, Clamshell, And Stretch Carding

  Tight timelines and coordinated packaging execution drove a high-stakes product launch ahead of a national competitor, ultimately capturing over half the market and setting a new benchmark.

• Ensuring Supply Through Speed And Transparency

  Through speed, transparency, and close collaboration, the pharmaceutical company was able to switch vendors seamlessly, maintaining virtually uninterrupted manufacturing operations.

• Use Of Epiontis ID In A Phase 2 Psoriasis Trial

  Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.

• What Unified eCOA And IRT Can Unlock

  See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.

• Flexible Data Management For Growing Portfolio

  Explore strategic enhancements to a small biopharma's biometrics capabilities involving the deployment of 20 specialized professionals, which effectively bolstered the client’s organizational capacity.

• How Vanguard Clinical Harnesses CDMS/EDC For Faster Results

  Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.